Allergicheskiy rinit. Vozmozhnosti preventivnoy terapii


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Allergic rhinitis is a serious medical and social problem associated with a high morbidity and high economic expenses for rhinitis management. The conducted studies demonstrated expediency of treatment with intranasal steroids, the most suitable medication for a prevention strategy, because they target the inflammatory cascade at multiple points and yield measurable symptom relief when administered preventively.

Full Text

Restricted Access

About the authors

A. Yu Nasunova

O. S Drobik

References

  1. Meltzer EO, et al. Sleep, quality of life, and productivity impact of nasal symptoms in the United States: findings from the Burden of Rhinitis in America survey. Allergy Asthma Proc 2009;30(3):244-54.
  2. Nathan RA. The burden of allergic rhinitis. Allergy Asthma Proc 2007;28(1):3-9.
  3. Dykewicz MS, Hamilos DL. Rhinitis and sinusitis. J Allergy Clin Immunol 2010;125(2 Suppl. 2): 103-15.
  4. Derendorf H, Meltzer EO. Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications. Allergy 2008;63(10):1292-300.
  5. Wallace DV, et al. Joint Task Force on Practice; American Academy of Allergy; Asthma & Immunology; American College of Allergy; Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol 2008;122(Suppl. 2):1-84.
  6. Connell JT. Quantitative intranasal pollen challenge. II. Effect of daily pollen challenge, environmental pollen exposure, and placebo challenge on the nasal membrane. J Allergy 1968;41(3):123-39.
  7. Connell JT. Quantitative intranasal pollen challenges. III. The priming effect in allergic rhinitis. J Allergy 1969;43(1):33-44.
  8. Milanese M, et al. Eosinophils, specific hyperreactivity and occurrence of late phase reaction in allergic rhinitis. Eur Ann Allergy Clin Immunol 2005;37(1):7-10.
  9. Bousquet J, et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008;63(Suppl. 86): 8-160.
  10. Ariano R, et al. Possible role of climate changes in variations in pollen seasons and allergic sensitizations during 27 years. Ann Allergy Asthma Immunol 2010;104(3):215-22.
  11. Ziska L, et al. Recent warming by latitude associated with increased length of ragweed pollen season in central North America. Proc Natl Acad Sci USA 2011;108(10):4248-51.
  12. Ellis AK, et al. Factors that affect the allergic rhinitis response to ragweed allergen exposure. Ann Allergy Asthma Immunol 2010;104(4):293-8.
  13. Parker JD, et al. Air pollution and childhood respiratory allergies in the United States. Environ Health Perspect 2009;117(1):140-47.
  14. Sehlstedt M, et al. Airway inflammatory response to diesel exhaust generated at urban cycle running conditions. Inhal Toxicol 2010;22(14): 1144-50.
  15. Yoshizaki K, et al. Subchronic effects of nasally instilled diesel exhaust particulates on the nasal and airway epithelia in mice. Inhal Toxicol 2010;22(7):610-7.
  16. Ciprandi G, et al. Minimal persistent inflammation is present at mucosal level in patients with asymptomatic rhinitis and mite allergy. J Allergy Clin Immunol 1995;96(6 pt 1):971-79.
  17. Braunstahl GJ, et al. Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways. J Allergy Clin Immunol 2001;107(3):469-76.
  18. Pelikan Z. Asthmatic response induced by nasal challenge with allergen. Int Arch Allergy Immunol 2009;148(4):330-38.
  19. Crystal-Peters J, et al. Treating allergic rhinitis in patients with comorbid asthma: the risk of asthma-related hospitalizations and emergency department visits. J Allergy Clin Immunol 2002;109(1):57-62.
  20. Bousquet J, et al. Aria Workshop Group; World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108(Suppl. 5):147-334.
  21. Lack G, et al. The link between otitis media with effusion and allergy: a potential role for intranasal corticosteroids. Pediatr Allergy Immunol 2011;22(3):258-66.
  22. Marple BF. Targeting congestion in allergic rhinitis: the importance of intranasal corticosteroids. Allergy Asthma Proc 2008;29(3):232-40.
  23. Meltzer EO. The pharmacological basis for the treatment of perennial allergic rhinitis and non-allergic rhinitis with topical corticosteroids. Allergy. 1997;52(Suppl 36):33-40.
  24. Frieri M, et al. Effect of mometasone furoate on early and late phase inflammation in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol 1998;81(5 pt 1):431-37.
  25. Pitsios C, et al. Efficacy and safety of mometasone furoate vs nedocromil sodium as prophylactic treatment for moderate/severe seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2006;96(5):673-78.
  26. Bousquet J, et al. Prevention of pollen rhinitis symptoms: comparison of fluticasone propionate aqueous nasal spray and disodium cromoglycate aqueous nasal spray. A multicenter, doubleblind, double-dummy, parallel-group study. Allergy 1993;48(5):327-33.
  27. Juniper EF, et al. Comparison of beclomethasone dipropionate aqueous nasal spray, astemizole, and the combination in the prophylactic treatment of ragweed pollen-induced rhinoconjunctivitis. J Allergy Clin Immunol 1989;83(3):627-33.
  28. Blaiss MS. Safety considerations of intranasal corticosteroids for the treatment of allergic rhinitis. Allergy Asthma Proc 2007; 28(2):145-52.
  29. Meltzer EO, et al. Safety and tolerability of fluticasone furoate nasal spray once daily in paediatric patients aged 6-11 years with allergic rhinitis: subanalysis of three randomized, double-blind, placebo-controlled, multicentre studies. Clin Drug Investig 2009; 29(2):79-86.
  30. Nasonex prescribing information. Whitehouse Station, NJ: Merck & Co., Inc; 2011.
  31. Veramyst prescribing information. Research Triangle Park, NC: GlaxoSmithKline; 2011.
  32. Bielory L, et al. Impact of mometasone furoate nasal spray on individual ocular symptoms of allergic rhinitis: a meta-analysis. Allergy 2011;66(5):686-93.
  33. Baiardini I, et al. Effects of mometasone furoate on the quality of life: a randomized placebo-controlled trial in persistent allergic rhinitis and intermittent asthma using the Rhinasthma questionnaire. Clin Exp Allergy 2011;41(3):417-23.
  34. Fromer L, et al. Assessment of patient attitudes about mometasone furoate nasal spray: The Ease-of-Use Patient Survey. World Allergy Organiz J 2008;1(9):156-59.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2013 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies